— Know what they know.
Not Investment Advice
Also trades as: FEERF (OTC) · $vol 0M

FRI.V TSXV

Freeport Resources Inc.
1W: +18.2% 1M: +30.0% 3M: +30.0% YTD: -31.6% 1Y: +116.7% 3Y: +62.5% 5Y: -70.5%
C$0.07 ($0.05)
+0.01 (+8.33%)
 
Weekly Expected Move ±16.5%
C$0 C$0 C$0 C$0 C$0
TSXV · Basic Materials · Other Precious Metals · Tech Score Neutral · Power 54 · C$24.7M mcap · 376M float · 0.024% daily turnover

Balance Sheet Trends

Total Assets
$3M +234.9% ▲
5Y CAGR: +227.2%
Total Liabilities
$123K +6.0% ▲
5Y CAGR: -43.0%
Shareholders Equity
$2M +275.1% ▲
Cash & Investments
$2M +279.7% ▲
5Y CAGR: +327.9%
Total Debt
$0 +0.0% ▲
Net Debt
-$2M -279.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3M$1M$1M$633K$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3M$1M$1M$633K$2M
Net Receivables$27K$42K$27K$9K$82K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$3M$2M$1M$778K$3M
Property, Plant & Equip.$5$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$5$0$0$0$0
Total Assets$3M$2M$1M$778K$3M
— Liabilities —
Accounts Payable$112K$138K$655K$46K$64K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$130K$153K$685K$116K$123K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$130K$153K$685K$116K$123K
— Equity —
Common Stock$17M$22M$22M$25M$30M
Retained Earnings-$16M-$22M-$24M-$26M-$30M
Accumulated OCI$2M-$5K-$19K-$30K-$71K
Total Stockholders Equity$3M$1M$593K$662K$2M
Total Liabilities & Equity$3M$2M$1M$778K$3M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$3M-$1M-$1M-$633K-$2M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms